Results 191 to 200 of about 1,353,059 (301)

Pulmonary hypertension in pregnancy: hemodynamic challenges, maternal risk, and multidisciplinary management. [PDF]

J Cardiovasc Imaging
Chang SA.
europepmc   +1 more source

Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon, Wendy Wang, Faye L. Norby, Rob F. Walker, Shalini Kulasingam, Lisa S. Chow, Joel F. Farley, Pamela L. Lutsey   +7 more
wiley   +1 more source

The Epidemiology of Pulmonary Hypertension in Sub-Saharan Africa-A Systematic Report. [PDF]

Pulm Circ
Zeder K, Wang L, Ngah V, Santi A, Robbins EW, Mocumbi AO, Namuyonga J, Nyasulu P, Kovacs G, Humbert M, Strange G, Stewart S, Diao G, Maron BA.   +13 more
europepmc   +1 more source

Twenty years of inhaler therapy: A nationwide drug utilization study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to map nationwide trends and prescribing patterns in inhaler use from 2004 to 2023. In light of evolving clinical guidelines and attention to the environmental impact of inhalers within recent years, we also examined variation in prescribing behaviour and patient‐level treatment choices. Methods Using nationwide health registries,
Katrine Bitsch Johansen, Lars Christian Lund, Zandra Nymand Ennis, Andrew Scourfield, Anders Løkke, Sidsel Arnspang Pedersen   +5 more
wiley   +1 more source

Preoperative TAPSE/sPAP ratio predicts early residual pulmonary hypertension following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. [PDF]

BMC Pulm Med
Ma J, Ren D, Zhen Y, Li A, Duan J.
europepmc   +1 more source

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

British Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink, Iris R. Joosse, Maximilian Salcher‐Konrad, Melanie Walter, Elena Deligianni, Dimitra Tsioumela, Christos Kontogiorgis, Elita Poplavska, Iluta Žīgure, Christina E. Hoeve, Teresa Leonardo Alves, Ella D. van Vliet, Renato Ferreira‐da‐Silva, Ana Kodrič, Mitja Kos, Juan Erviti, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Sofia Kälvemark Sporrong, Emelie Karlsson, Christine Leopold, Marie L. De Bruin   +21 more
wiley   +1 more source

Clinical phenotypes and the risk factors of mild pulmonary hypertension. [PDF]

JHLT Open
Taya S, Ejiri K, Akagi S, Fukuda Y, Kanezawa M, Takaya Y, Miyoshi T, Nakamura K, Yuasa S.   +8 more
europepmc   +1 more source

Incident low‐dose quetiapine use in adults newly diagnosed with depression in primary care: A nationwide register‐based study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to investigate the incidence of low‐dose quetiapine initiation and associated factors in adults newly diagnosed with depression in primary care. Methods We obtained medication dispensing records, primary and secondary care diagnoses and employment status for antipsychotic‐naïve individuals aged 16–65 newly diagnosed with ...
Laura Purra, Heidi Taipale, Miia Tiihonen, Markku Lähteenvuo, Jari Tiihonen, Aleksi Hamina   +5 more
wiley   +1 more source

Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension. [PDF]

J Am Heart Assoc
Farha S, Hu B, Chen R, Barnard J, Comhair S, Heresi G, Parambil J, Tonelli A, Beck G, Berman-Rosenzweig E, DuBrock H, Finet JE, Frantz RP, Grunig G, Hassoun PM, Hemnes AR, Hill N, Horn E, Jellis C, Leopold JA, Park MM, Rischard FP, Simpson C, Tang WHW, Olman MA, Erzurum SC, Dweik RA, PVDOMICS Study Group.   +27 more
europepmc   +1 more source

Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Safe prescribing and effective medication review during acute hospitalization depends on accurate information about liver and kidney function because these organs are responsible for the elimination of most medications. While estimates for kidney function are widely used, comparable markers of hepatic drug‐metabolizing capacity are not routinely ...
Louise Westberg Strejby Christensen, Anne Kirstine Boas, Emilie Clausen, Nicoline Elers Koch, Anne Byriel Walls, Lotte Stig Nørgaard, Michael Asger Andersen, Anissa Aharaz, Rikke Lundsgaard Nielsen, Olivia Bornæs, Juliette Tavenier, Baker Nawfal Jawad, Helle Gybel Juul‐Larsen, Esben Iversen, Ove Andersen, Lona Louring Christrup, Kim Peder Dalhoff, Morten Baltzer Houlind   +17 more
wiley   +1 more source